论文部分内容阅读
1 文献类型治疗2 证据水平1b3 文献来源①Belani CP,Larocca RV,Rinaldi DA,et al.A multicenter,phase Ⅲ randomized trial for stage Ⅲ B/Ⅳ NSCLC of weekly paclitaxel and carboplatin vs standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel. P